US Patent Issued to Regeneron Pharmaceuticals, California Institute of Technology on Nov. 25 for "AKT-specific capture agents, compositions, and methods of using and making" (California, Washington Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,950, issued on Nov. 25, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.) and California Institute of Technology (Pasadena, Calif.).

"AKT-specific capture agents, compositions, and methods of using and making" was invented by James R. Heath (South Pasadena, Calif.), Arundhati Nag (Pasadena, Calif.), Samir Das (Pasadena, Calif.), Kaycie M. Deyle (Sylmar, Calif.), Steven Wesley Millward (Monrovia, Calif.) and Paul Edward Kearney (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides stable peptide-based Akt capture agents and the use thereof as detection, diagnosis, and treatment agents. The application...